HeartWare names Peter F. McAree as CFO

Monday, July 9, 2012 04:48 PM

HeartWare International, a developer of less invasive, miniaturized circulatory support technologies for treatment of advanced heart failure, has appointed Peter F. McAree as senior vice president, CFO and Treasurer

McAree brings more than 25 years of financial management and public accounting experience to HeartWare International. He most recently served as senior vice president and CFO at Caliper Life Sciences, prior to the company's acquisition by PerkinElmer in November, 2011. McAree also served as CFO of Zymark prior to the company's merger with Caliper in 2003. 

Outside the pharmaceutical and medical device industry, McAree has served in many financial leadership positions, including Arthur Andersen and Enterprise Group.

Share:          
CWWeekly

March 2

Huntingdon Life Sciences-Harlan prepares for rebranding and U.S. expansion to compete with early phase CROs Covance, CRL

Patients' increased sharing of clinical trial experiences through social media can help sponsors improve outcomes, enrollment

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

March

Novo Nordisk, Takeda, Servier, Celgene among top sponsors
New gains seen from patient- and site-centric initiatives

Patient reported outcomes take center stage
FDA combining PROs, clinical outcomes in its approval decisions

Already a subscriber?
Log in to your digital subscription.

Purchase the March issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

February

Study grants market breaks $13 billion
Volume of clinical activity rising while growth in grant spending slows

Revisiting eClinical Technology Solutions Adoption
While use of established solutions grows, sponsors hesitate on newer tools

Already a subscriber?
Log in to your digital subscription.

Purchase the February issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs